Dynamic Monitoring of Circulating Tumor DNA to Predict the Risk of Non In Situ Recurrence of Postoperative Glioma: A Prospective Cohort Study
ABSTRACT Background Glioma recurrence can be divided into in situ recurrence and non‐in situ recurrence, and the mutation evolution of gliomas with different recurrence patterns is still unknown. We used sequential sequencing of circulating tumor DNA (ctDNA) to compare the somatic mutation profile a...
Saved in:
| Main Authors: | Guangzhong Guo, Ziyue Zhang, Jiubing Zhang, Dayang Wang, Sensen Xu, Shuang Wu, Kaiyuan Deng, Yage Bu, Zhiyuan Sheng, Jinliang Yu, Yushuai Gao, Zhaoyue Yan, Ruijiao Zhao, Meiyun Wang, Tianxiao Li, Xingyao Bu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-03-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.70733 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CTO inhibits the in situ growth of glioblastoma in mice and regulates the metabolism and inflammatory phenotype of glioma-associated microglia
by: LI Yunfan, ZOU Jiaming, WANG Yucheng, JU Rui, GUO Lei
Published: (2025-04-01) -
Panoramic spatial enhanced resolution proteomics (PSERP) reveals tumor architecture and heterogeneity in gliomas
by: Ziyan Xu, et al.
Published: (2025-05-01) -
The Multi-Voxel MRS of Glioma: Glycine is a Suitable Biomarker for Tumor Grading
by: Hossein Taheri, et al.
Published: (2025-07-01) -
Cognitive impairments in patients with low grade gliomas and high grade gliomas
by: Eliane C. Miotto, et al.
Published: (2011-08-01) -
Breed-Associated Differences in Differential Gene Expression Following Immunotherapy-Based Treatment of Canine High-Grade Glioma
by: Susan A. Arnold, et al.
Published: (2024-12-01)